ReVision Optics to Continue Enrollment of Phase 3 Trial of the Raindrop Near Vision Inlay
ReVision Optics, Inc., has received conditional approval
from the FDA to continue and complete enrollment in
its phase 3 clinical trial of the Raindrop Near Vision Inlay
(formerly the PresbyLens), according to a news release.
The prospective, multicenter trial is evaluating the safety
and effectiveness of the patented,...